1977
DOI: 10.1111/j.1365-2044.1977.tb10078.x
|View full text |Cite
|
Sign up to set email alerts
|

Estimation of plasma lorazepam by gas‐liquid chromatography and a benzene extraction

Abstract: Lorazepam, a new long-acting benzodiazepine, has been in clinical use for about one year. As part of its evaluation as a premedicant it was necessary to correlate plasma levels with clinical assessment after various modes of administration. A method of extracting lorazepam from plasma was obtained from the manufacturers but proved to be unsuitable when large numbers of samples had to be analysed. It involved a number of stages. A similar method was reported by Knowles, Comer and Ruelius. 'In 1975 Gamble and hi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1980
1980
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…Analytical methods for LZP in biological fluids are problematic, due to the high sensitivity required to detect the low unconjugated blood (plasma/serum) LZP concentrations achieved after the recommended doses, and the thermal instability of the 3-hydroxybenzodiazepine ring. Previously published GC methods for the quantification of LZP and/or conjugated glucuronide metabolites in biological matter (whole blood, plasma/serum urine, or brain) include GC-ECD [19][20][21][22]45]; GC-NPD [19,23]; GC-MS [25,26] and GC-MS/NICI [27,28] or GC-MS/SIM [24,28,30]. Several HPLC methods with UV or diode array detection [31][32][33][34][35][36][37][38][39][40][41]43] and mass spectrometric detection [43] have also been reported.…”
Section: Discussionmentioning
confidence: 99%
“…Analytical methods for LZP in biological fluids are problematic, due to the high sensitivity required to detect the low unconjugated blood (plasma/serum) LZP concentrations achieved after the recommended doses, and the thermal instability of the 3-hydroxybenzodiazepine ring. Previously published GC methods for the quantification of LZP and/or conjugated glucuronide metabolites in biological matter (whole blood, plasma/serum urine, or brain) include GC-ECD [19][20][21][22]45]; GC-NPD [19,23]; GC-MS [25,26] and GC-MS/NICI [27,28] or GC-MS/SIM [24,28,30]. Several HPLC methods with UV or diode array detection [31][32][33][34][35][36][37][38][39][40][41]43] and mass spectrometric detection [43] have also been reported.…”
Section: Discussionmentioning
confidence: 99%
“…as required. Venous blood was drawn from both groups at 0, 7.5, 15, 30, 60 and 90 min and at 2, 4, 6, 8, 10 and 12 h after the initial dose, and the plasma concentrations of each benzodiazepine measured (gas-liquid chromatography) (Gamble et al, 1975;Howard et al, 1978). (The coefficient of variation of our analyses was 3.4% for diazepam, 9?8 % for low concentrations of midazolam and 1.8% for high concentrations.)…”
Section: Methodsmentioning
confidence: 99%
“…Plasma lorazepam and diazepam estimations were by gas-liquid chromatography (Howard et al, 1977;Gamble et al, 1975). Cimetidine does not interfere with either of these determinations.…”
Section: Introduction Methodsmentioning
confidence: 99%